HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery.

AbstractOBJECTIVES:
We made a comparative study of laparoscopic nephroureterectomy (LNU) and standard open surgery (ONU) for upper urinary tract transitional cell carcinoma.
METHODS AND METHODS:
From July 2000 to February 2005, 49 patients underwent total nephroureterectomy for upper tract transitional cell carcinoma at Osaka University Medical Hospital. Of the 49 patients, twenty-five were treated with LNU, and twenty-four with ONU. Each group of cases was reviewed with respect to operative time, complications and postoperative convalescence.
RESULTS:
The average operative time of the LNU and ONU group was 305.9 min (range 190-480) and 271.2 min (range 135-480) respectively, and the average blood loss was 321.5 ml (80-1370) and 557.7 ml (range 100-1730), respectively. The average time until ambulation after LNU and ONU was 2.2 days (range 1-3) and 4.0 days (range 3-5), respectively. No major postoperative complications were observed in either group.
CONCLUSION:
ONU still represents the gold standard for the management of upper tract transitional cell carcinoma; however, for low stage cases, LNU offers the advantages of minimally invasive surgery.
AuthorsMasao Tsujihata, Norio Nonomura, Akira Tsujimura, Kazuhiro Yoshimura, Yasushi Miyagawa, Akihiko Okuyama
JournalEuropean urology (Eur Urol) Vol. 49 Issue 2 Pg. 332-6 (Feb 2006) ISSN: 0302-2838 [Print] Switzerland
PMID16387415 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell (mortality, pathology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Laparoscopy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nephrectomy (methods)
  • Nephrons (pathology, surgery)
  • Perioperative Care
  • Prognosis
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Ureter (pathology, surgery)
  • Urologic Neoplasms (mortality, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: